Agency: Nuclear Regulatory Commission
The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 1 and 2, 2004. An announcement of this meeting was originally made in the January 28, 2004 Federal Register. However, it is necessary to reannounce this meeting because the NRC staff has since determined that
The ACRS Subcommittee on Planning and Procedures will hold a meeting on March 3, 2004, Room T2B1, 11545 Rockville Pike, Rockville, Maryland.
The entire meeting will be open to public attendance, with the exception of a portion that may be closed pursuant to 5 U.S.C. 552b(c) (2) and (6) to discuss organizational and personnel matters that
Dates: Weeks of February 16, 23; March 1, 8, 15, 22, 2004.
Place: Commissioners' Conference Room, 11555 Rockville Pike, Rockville, Maryland.
Status: Public and closed.
Matters to be Considered:
Week of February 16, 2004
Wednesday, February 18, 2004
9:30 a.m. Briefing on Status of Office of the Chief Financial Officer Programs, Performance, and Plans
On February 3, 2004 (69 FR 5200), the Federal Register published the ``Biweekly Notice of Applications and Amendments to Operating Licenses Involving No Significant Hazards Considerations.'' On page 5216, Southern Nuclear Operating Company, Inc., et al., Vogtle Electric Generating Plant, Units 1 and 2, ``Amendment Nos. 130 and 108'' should
This document corrects a notice appearing in the Federal Register on January 5, 2004 (69 FR 385)), that clarifies that enforcement action may be taken against nonlicensees for violations of the Commission's regulations governing the packaging and transportation of radioactive material. This action is necessary to: (1) Include the deadline for
The U.S. Nuclear Regulatory Commission plans to make a clarification in the reporting guideline for serious steam generator tube degradation contained within Revision 2 to NUREG1022, ``Event Reporting Guidelines 10 CFR 50.72 and 50.73.'' The NRC intends to issue an errata to NUREG1022, Revision 2. The purpose of this clarification is to ensure